Migraines are around 1.5 to 2 times more common in women with PMOS than in the general female population, with most having menstrual migraine patterns triggered by the estrogen drop in the late luteal phase. The 5 PMOS-specific migraine drivers: estrogen fluctuations at the luteal-menstrual transition, insulin-driven post-meal glucose swings (insulin resistance is in 70 percent of women with PMOS), magnesium deficiency, dehydration (compounded by caffeine intake), and sleep disruption. The 6-step prevention plan: 30/30/40 macros with calorie front-loading, magnesium glycinate 300 to 400mg evening, riboflavin (B2) 400mg/day, omega-3 2 to 3g/day, consistent sleep schedule, and trigger identification through tracking. Most women reduce migraine frequency by 40 to 60 percent within 8 to 12 weeks on a comprehensive plan. PMOS is the new name for PCOS as of 12 May 2026; migraine evidence is identical under both names.
Why migraines are more common in PMOS
Five biological factors increase migraine frequency and severity in PMOS:
1. Estrogen fluctuations
The most common PMOS migraine pattern is menstrual migraine: headaches triggered by the estrogen drop in the late luteal phase (the few days before a period). Estrogen affects serotonin and CGRP (calcitonin gene-related peptide), key migraine pathway components. Women with irregular PMOS cycles often have less predictable but more severe estrogen fluctuations, producing more frequent migraines.
2. Insulin-driven glucose swings
Post-meal glucose swings can trigger migraines via vascular and inflammatory mechanisms. Insulin resistance (in 70 percent of women with PMOS) produces sharper post-meal swings and the post-meal dip that follows, both of which are recognised migraine triggers in some women.
3. Magnesium deficiency
Magnesium plays a role in vascular regulation and neuronal excitability. The 2024 Cephalalgia review of magnesium in migraine prevention found around 40 percent reduction in migraine frequency at 400-600mg/day in trials. Women with PMOS often have lower magnesium status due to insulin resistance increasing urinary magnesium loss.
4. Dehydration and caffeine patterns
Mild dehydration is a common migraine trigger. PMOS does not directly cause dehydration but caffeine intake (without adequate water alongside) can contribute. Caffeine itself has a complex migraine relationship: regular moderate intake can be neutral or protective, but rebound headaches occur when accustomed intake is missed.
5. Sleep disruption
Sleep disruption (around 30x higher sleep apnoea risk in PMOS, elevated insomnia) is a major migraine trigger. Inadequate or fragmented sleep raises next-day migraine risk significantly.
The PMOS migraine timing patterns
| Migraine pattern | Typical timing | PMOS relevance |
|---|---|---|
| Menstrual migraine | 2 days before to 3 days into the period | Most common in PMOS due to estrogen fluctuations |
| Mid-cycle migraine | Around ovulation if cycling regularly | Less common in PMOS due to irregular cycles |
| Post-meal headache | 1-3 hours after carb-heavy meals | Insulin-driven; common in insulin-resistant phenotype |
| Stress headache | During or after stressful periods | Cortisol-driven; common in adrenal phenotype |
| Wake-up headache | Morning, before getting out of bed | Often sleep apnoea; PMOS has 30x higher OSA risk |
| Hangover headache | Morning after alcohol | PMOS women often more sensitive |
The 6-step PMOS migraine prevention plan
Step 1: 30/30/40 macros with calorie front-loading
Stable blood glucose reduces post-meal migraine triggers. The Jakubowicz 2013 calorie-front-loading pattern reduces glucose swings substantially. Avoid skipping meals (a recognised migraine trigger) and avoid high-sugar meals.
Step 2: Magnesium glycinate 300-400mg evening
The 2024 Cephalalgia review found around 40 percent migraine frequency reduction at 400-600mg/day of magnesium in 8-12 week trials. Glycinate form is best tolerated. Take evening for sleep benefit alongside migraine prevention.
Step 3: Riboflavin (vitamin B2) 400mg/day
Riboflavin is one of the most evidence-backed migraine preventives. The 1998 Schoenen trial showed around 50 percent reduction in migraine frequency at 400mg/day over 3 months, with effects continuing in maintenance phases. Generally well-tolerated; can turn urine bright yellow which is harmless.
Step 4: Omega-3 (EPA+DHA) 2-3g/day
The 2021 BMJ study on omega-3 and migraine found around 30 percent reduction in monthly migraine days at 2-3g/day over 16 weeks. Anti-inflammatory mechanism. Algae oil works equally well as fish oil. Standard PMOS dose.
Step 5: Consistent sleep schedule
Same bedtime within 30 minutes most nights. 7-9 hours total. Screen for sleep apnoea if any signs (waking unrefreshed, morning headaches, partner notices snoring). Treating undiagnosed sleep apnoea often dramatically reduces migraine frequency.
Step 6: Trigger identification through tracking
Track migraines alongside food, sleep, stress, cycle, and weather for 2-3 months. Common identifiable triggers:
- Specific foods (aged cheese, processed meats, red wine, chocolate for some)
- Sleep disruption
- Skipped meals
- Dehydration
- Stress (often delayed; weekend migraines after a stressful week)
- Weather changes (especially barometric pressure drops)
- Bright or flickering lights
- Strong smells
- Specific cycle days
Apps like Migraine Buddy, N1-Headache, or paper diary all work. The pattern usually emerges in 4-8 weeks of tracking.
Acute migraine treatment for PMOS women
For acute attacks, standard migraine medications apply. PMOS does not change first-line treatment significantly:
- NSAIDs (ibuprofen, naproxen): first-line for mild to moderate migraines. Take early in the attack.
- Triptans (sumatriptan, rizatriptan, eletriptan, etc.): first-line for moderate to severe migraines. Various delivery routes (oral, nasal, injectable). Discuss with your clinician for the right choice.
- Gepants (ubrogepant, rimegepant): newer CGRP-pathway medications. Useful for women with cardiovascular contraindications to triptans (relevant in PMOS due to elevated cardiovascular risk).
- Anti-nausea medications (ondansetron, metoclopramide): often paired with acute treatment.
For frequent migraines (more than 4 per month), preventive medications may be appropriate:
- Topiramate or amitriptyline: traditional preventives. Some weight loss with topiramate (relevant for PMOS).
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab): monthly or quarterly injections, very effective. Often first-line preventive in 2026.
- Beta blockers (propranolol): traditional, well-evidenced.
Hormonal management for menstrual migraine in PMOS
Menstrual migraine specifically can be helped by hormonal interventions:
- Continuous combined oral contraceptives (skipping the placebo week) eliminate the cyclical estrogen drop that triggers menstrual migraines. Effective for many women.
- Transdermal estrogen during the late luteal phase (estrogen patches or gel for 5-7 days) prevents the estrogen drop. Specialist-managed approach.
- Important caveat: migraine with aura is a contraindication for combined oral contraceptives (small but real stroke risk increase). Discuss carefully with your clinician.
Frequently asked questions
Why do I get more migraines with PMOS?
5 PMOS-specific drivers: estrogen fluctuations (luteal-menstrual transition triggers menstrual migraines), insulin-driven glucose swings, magnesium deficiency (worsened by insulin resistance), dehydration patterns, and sleep disruption (30x higher OSA risk in PMOS).
How do I prevent migraines with PMOS?
6-step plan: 30/30/40 macros with calorie front-loading, magnesium glycinate 300-400mg evening (40% migraine frequency reduction in trials), riboflavin 400mg/day (50% reduction in 1998 Schoenen trial), omega-3 2-3g/day (30% reduction per 2021 BMJ), consistent sleep schedule with sleep apnoea screening, trigger identification through 2-3 months of tracking.
Is magnesium good for PMOS migraines?
Yes. 2024 Cephalalgia review found around 40 percent migraine frequency reduction at 400-600mg/day in 8-12 week trials. Magnesium glycinate is best tolerated (300-400mg evening). Pairs with the standard PMOS magnesium supplementation.
Does diet affect PMOS migraines?
Yes. The 30/30/40 PMOS dietary pattern with calorie front-loading reduces post-meal glucose swings that can trigger migraines. Identifying personal trigger foods (aged cheese, processed meats, red wine, chocolate for some) through 2-3 months of tracking adds further benefit. Skipping meals is a common trigger to avoid.
Are menstrual migraines common in PMOS?
Yes. Menstrual migraine (2 days before to 3 days into the period) is the most common pattern in PMOS due to estrogen fluctuations. Continuous combined oral contraceptives (skipping placebo weeks) or transdermal estrogen during the late luteal phase can prevent these. Migraine with aura is a contraindication for COCs.
Can sleep apnoea cause migraines in PMOS?
Yes. Wake-up headaches (morning, before getting out of bed) often indicate undiagnosed sleep apnoea. PMOS has around 30x higher OSA risk than the general female population. Treating OSA often dramatically reduces migraine frequency.
Should I take CGRP medications for PMOS migraines?
CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) are very effective preventives for frequent migraine (more than 4 per month) and are often first-line in 2026. Monthly or quarterly injections. Particularly useful for women with cardiovascular contraindications to triptans (relevant for PMOS due to elevated cardiovascular risk).
How long until the migraine prevention plan works?
Magnesium and dietary effects often emerge in 4-6 weeks. Riboflavin and omega-3 effects emerge at 8-12 weeks. CGRP medications work within 1-2 months. Most women see 40-60 percent migraine frequency reduction on a comprehensive 6-step plan within 8-12 weeks.
Build a PMOS plan that supports migraine prevention
The 30/30/40 PMOS dietary pattern reduces glucose swings that trigger migraines.
Stable blood sugar plus the right supplements addresses most PMOS migraines. Take the free phenotype quiz to start.
What to read next
- PMOS sleep
- PMOS and birth control
- Best PMOS supplements
- PMOS stress and cortisol
- PCOS is now PMOS: full renaming explainer
How this article was researched
Sources include the 2024 Cephalalgia review of magnesium in migraine prevention, the 1998 Schoenen riboflavin in migraine trial, the 2021 BMJ omega-3 and migraine study, the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, and the 2024 American Headache Society guidance on migraine prevention. PCOS was renamed PMOS on 12 May 2026; migraine evidence is unchanged. This article is informational and not medical advice. See our editorial standards.
Community Comments
Add a comment